Ubs Asset Management Americas Inc Spectrum Pharmaceuticals Inc Transaction History

Ubs Asset Management Americas Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.89 - $4.45 $87,471 - $134,688	-30,267 Reduced 16.02%	158,669 $595,000
Q1 2021 May 14, 2021	BUY	$2.9 - $4.09 $118,505 - $167,133	40,864 Added 27.6%	188,936 $615,000
Q4 2020 Mar 01, 2021	BUY	$3.38 - $5.14 $105,807 - $160,902	31,304 Added 26.81%	148,072 $504,000
Q3 2020 Nov 13, 2020	BUY	$2.99 - $4.9 $75,575 - $123,852	25,276 Added 27.63%	116,768 $476,000
Q2 2020 Aug 14, 2020	BUY	$2.11 - $3.38 $18,462 - $29,575	8,750 Added 10.58%	91,492 $309,000
Q1 2020 May 15, 2020	BUY	$1.83 - $3.45 $1,745 - $3,291	954 Added 1.17%	82,742 $192,000
Q4 2019 Feb 14, 2020	BUY	$3.5 - $10.35 $44,275 - $130,927	12,650 Added 18.3%	81,788 $297,000
Q3 2019 Nov 14, 2019	BUY	$7.03 - $9.7 $98,019 - $135,247	13,943 Added 25.26%	69,138 $573,000
Q2 2019 Aug 15, 2019	BUY	$7.36 - $11.26 $12,725 - $19,468	1,729 Added 3.23%	55,195 $0
Q1 2019 May 14, 2019	BUY	$9.08 - $11.84 $65,893 - $85,922	7,257 Added 15.7%	53,466 $0
Q4 2018 Feb 13, 2019	SELL	$6.39 - $16.99 $84,066 - $223,520	-13,156 Reduced 22.16%	46,209 $404,000
Q2 2018 Aug 14, 2018	SELL	$14.31 - $21.75 $6,153 - $9,352	-430 Reduced 0.72%	59,365 $0
Q1 2018 May 14, 2018	BUY	$16.09 - $23.07 $59,806 - $85,751	3,717 Added 6.63%	59,795 $0
Q4 2017 Feb 09, 2018	BUY	$13.36 - $20.73 $210,366 - $326,414	15,746 Added 39.04%	56,078 $0
Q3 2017 Nov 13, 2017	BUY	$8.75 - $14.07 $352,905 - $567,471	40,332	40,332 $0

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.